Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis

Shock

Volumn 27, Issue 4, 2007, Pages 373-379

  Lee, H Thomas ^a,b   Emala, Charles W ^a   Joo, Jin Deok ^a   Kim, Mihwa ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acute renal failure; Apoptosis; Cecal ligation and puncture; Hepatic dysfunction; Inflammation

Indexed keywords

CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOFLURANE; MESSENGER RNA; PENTOBARBITAL; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; INTESTINE PERFORATION; KIDNEY CORTEX; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE ABSORPTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER PROTECTION; MALE; MEDICAL ASSESSMENT; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PYLORUS LIGATION; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; THERAPY EFFECT; TREATMENT RESPONSE;

ANESTHETICS, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; ISOFLURANE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; PERITONITIS; SEPSIS; SURVIVAL;

EID: 34247100304     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000248595.17130.24     Document Type: Article

References (34)

1. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
2. Scott MJ, Godshall CJ, Cheadle WG: Jaks, STATs, cytokines, and sepsis. Clin Diagn Lab Immunol 9:1153-1159, 2002.
3. Shayevitz JR, Rodriguez JL, Gilligan L, Johnson KJ, Tait AR: Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome. Shock 4:61-67, 1995.
4. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101:1313-1324, 2004.
5. Lee HT, Kim M, Jan M, Emala CW: Anti-inflammatory and anti-necrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol 291:F67-F78, 2006.
6. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, Peter K: Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 86:188-195, 1997.
7. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF: Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 91:521-530, 1999.
8. Liu R, Ishibe Y, Ueda M, Hang Y: Isoflurane administration before ischemia and during reperfusion attenuates ischemia/reperfusion-induced injury of isolated rabbit lungs. Anesth Analg 89:561-565, 1999.
9. Liu R, Ishibe Y, Ueda M: Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. Anesthesiology 92:833-840, 2000.
10. Imai M, Kon S, Inaba H: Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats. Acta Anaesthesiol Scand 40:1242-1248, 1996.
11. Kon S, Imai M, Inaba H: Isoflurane attenuates early neutrophil- independent hypoxia-reoxygenation injuries in the reperfused liver in fasted rats. Anesthesiology 86:128-136, 1997.
12. Fink MP, Heard SO: Laboratory models of sepsis and septic shock. J Surg Res 49:186-196, 1990.
13. Gallos G, Jones DP, Nasr SH, Emala CW, Lee HT: Local anesthetics reduce mortality and protect against renal and hepatic dysfunction in murine septic peritonitis. Anesthesiology 101:902-911, 2004.
14. Gallos G, Ruyle TD, Emala CW, Lee HT: A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. Am J Physiol Renal Physiol 289:F369-F376, 2005.
15. Slot C: Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17:381-387, 1965.
16. Lee HT, Gallos G, Nasr SH, Emala CW: A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 15:102-111, 2004.
17. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME: Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15:1562-1574, 2000.
18. Aderem A, Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593-623, 1999.
19. Sawyer DW, Donowitz GR, Mandell GL: Polymorphonuclear neutrophils: an effective antimicrobial force. Rev Infect Dis 11(Suppl 7):1532-1544, 1989.
20. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC: Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 97:4-14, 2002.
21. Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Cardioprotection by volatile anesthetics. Vascul Pharmacol 42:243-252, 2005.
22. Smets D, Spapen H, Diltoer M, Nguyen DN, Hubloue I, Huyghens L: Liver perfusion and hepatocellular inflammatory response in sepsis. Acta Clin Belg 54:201-206, 1999.
23. Wang P, Chaudry IH: Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 270:R927-R938, 1996.
24. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
25. Heuer JG, Sharma GR, Gerlitz B, Zhang T, Bailey DL, Ding C, Berg DT, Perkins D, Stephens EJ, Holmes KC, et al.: Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med 32:1570-1578, 2004.
26. Remick DG, Bolgos G, Copeland S, Siddiqui J: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73:2751-2757, 2005.
27. Manley MO, O'Riordan MA, Levine AD, Latifi SQ: Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23:521-526, 2005.
28. Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70:4441-4446, 2002.
29. Plachinta RV, Hayes JK, Cerilli LA, Rich GF: Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology 98:89-95, 2003.
30. Fuentes JM, Talamini MA, Fulton WB, Hanly EJ, Aurora AR, De Maio A: General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock. Clin Vaccine Immunol 13:281-288, 2006.
31. Esmon CT: Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med 32:219-222, 2004.
32. Daemen MA, de Vries B, Buurman WA: Apoptosis and inflammation in renal reperfusion injury. Transplantation 73:1693-1700, 2002.
33. Daemen MA, de Vries B, van't Veer C, Wolfs TG, Buurman WA: Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation 71:1007-1011, 2001.
34. Daemen MA, van't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549, 1999.